메디포스트
8,970KRWMarket close of 10/20 (Tue)
Down -0.33%-30KRWMarket close of 10/20 (Tue)
Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/21 (Wed)8,820KRWDown -1.67%
Preliminary · just after the close · replaced by official KRX data tomorrow morning
- Open
- 9,050
- High
- 9,180
- Low
- 8,860
- Day range
- Day range low 8,860 high 9,180, open 9,050, close 8,970, previous close 9,000
- Volume
- 2×10K shares
- 207.37 million KRW 0.41× the 20-session average
Market close of 10/20 (Tue)
Where it sits in the 1-year range
7%1-year close range 7,520 to 28,000 won, 7% up from the low
7% of the way up from the lowest close in 1 year (252 sessions) · -68.0% from the high
Something to check
1 to check: operating loss
Free · no sign-inSource from 2021-05-17
Points to check
- Earningsto check-76.5B KRWOperating income over the last four quarters -76.5B KRW (loss)
- Daily moveusual range-0.33%-0.33%, 0.2× the usual (20-session average ±2.07%)That day -0.33% · usual ±2.07% · large-move threshold ±4.1%
- Trading valueusual range0.4×207.37 million KRW, 0.4× the 20-session average0.41× the 20-session average · check threshold 3×
The other 3 are within the usual range
- Recent filings0Last 14 days
- Foreign & institutional-100.00 million KRWusual range
- Data date10/20 (Tue)Market close
See the full check report
Same sector · 제약
Down -1.68%· 29 of 168 stocks up, preferred shares excluded · trading value 827.8B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 셀트리온 | Close over the last 20 sessions +11.4% | Down -0.40% | 139.2B KRW |
| 삼성바이오로직스 | Close over the last 20 sessions -1.3% | Down -2.52% | 129.9B KRW |
| 삼익제약 | Close over the last 20 sessions -20.4% | Up +2.77% | 76.0B KRW |
| 녹십자엠에스 | Close over the last 20 sessions +30.5% | Up +6.67% | 55.6B KRW |
| 유한양행 | Close over the last 20 sessions +11.5% | Down -1.37% | 41.6B KRW |
Schedule
- Q3 report due · 11/16 (Mon) · in 25 days
- Next data 10/22 (Thu) after 08:50
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.